Inoviem Scientific

Inoviem Scientific is a private Bioanalytical company which delivers enabling information to secure drug discovery programs and to take informed decision by closing the gap between preclinical and clinical development. We reconcile translational pharmacology and human physiology by using fresh patient material from the target cohort, embracing the complexity of human diseases. Inoviems enabling technologies are working in pathological conditions to get the treatment in development to the right patient. Our indication-agnostic access to patients combined with innovative label-free platforms deliver Target identification and validation, targets & Mode of Action deconvolution, patient stratification, predictive biomarkers and companion test to unlock...

Patient stratification,target identification,label-free technologies,mechanism of action elucidation,predictive biomarker identification,off target identification,target deconvolution,pharmacology,protein interactions,target validation,drug development,drug discovery,preclinical,clinical development,target engagament,patients,translational science,translational medicine,ex-vivo,drug repositioning ,drug upgrade,and compound screening

Inoviem scientific operates in the Biotechnology research industry.

Inoviem scientific's revenue is 11m - 100m

Inoviem scientific has 11 - 50 employees.